x

This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 




New therapeutic entities: The rise of the supergenerics

01-05-2015

Soledad Betanzos-Lara

New therapeutic entities: The rise of the supergenerics

ELLAGRIN / SHUTTERSTOCK.COM

It is unclear whether the so-called new therapeutic entities are qualified to be patented under current Mexican IP laws. Soledad Betanzos-Lara of Goodrich, Riquelme y Asociados examines the current landscape.


NTEs, patent, generics, New therapeutic entities, supergenerics

WIPR

Payment types accepted